Stock EIGR EIGER BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Delayed OTC Markets
Other stock markets
 12:43:04 2024-04-24 pm EDT 		5-day change 1st Jan Change
3.07 USD -22.28% Intraday chart for Eiger BioPharmaceuticals, Inc. +46.92% -53.97%
Apr. 10 Eiger BioPharmaceuticals, Inc.(NasdaqGM:EIGR) dropped from NASDAQ Composite Index CI
Apr. 08 Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
News Highlights : Top Company News of the Day - Monday at 11 PM ET
DJ
News Highlights : Top Company News of the Day - Monday at 7 PM ET
DJ
Citigroup Adjusts Eiger BioPharmaceuticals Price Target to $3 From $4, Maintains Buy Rating
MT
Baird Adjusts Price Target on Eiger BioPharmaceuticals to $5 From $3, Maintains Outperform Rating
MT
BTIG Adjusts Eiger BioPharmaceuticals' Price Target to $48 from $57, Maintains Buy Rating
MT
EIGER BIOPHARMACEUTICALS : Wedbush Suspended Coverage on Eiger BioPharmaceuticals
MT
EIGER BIOPHARMACEUTICALS : Citigroup Adjusts Price Target on Eiger BioPharmaceuticals to $26 From $23, Maintains Buy Rating
MT
EIGER BIOPHARMACEUTICALS : Wedbush Lifts Price Target for Eiger BioPharmaceuticals to $23 From $22, Maintains Outperform Rating
MT
EIGER BIOPHARMACEUTICALS : Wedbush Adjusts Price Target for Eiger BioPharmaceuticals to $22 From $31, Maintains Outperform Rating
MT
EIGER BIOPHARMACEUTICALS : Wedbush Adjusts Price Target on Eiger BioPharmaceuticals to $31 From $32, Keeps Outperform Rating
MT
Eiger BioPharmaceuticals, Inc. Announces Sub-Analysis of Phase 2 Results Demonstrating High Response Rates to 'All-Oral' Lonafarnib-Ritonavir Regimen in Low Viral Load Hdv-Infected Patients At the International Liver Congress 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EIGR Stock
  4. News Eiger BioPharmaceuticals, Inc.
  5. Analyst Reco.